LAG-3 antagonists by cancer treatment: a patent review

2019 
ABSTRACTIntroduction: LAG-3 is checkpoint inhibitor in cancer that coordinates the downregulation of the proliferation of antigen-specific lymphocytes. There is a great need to discover and develop...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    32
    References
    14
    Citations
    NaN
    KQI
    []